IQ-AI (IQAI) Competitors GBX 1.40 -0.05 (-3.45%) As of 02/21/2025 09:51 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines IQAI vs. INHC, TRLS, FDBK, DVRG, SENS, EMIS, CRW, INS, KOO, and RENXShould you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Induction Healthcare Group (INHC), Trellus Health (TRLS), Feedback (FDBK), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry. IQ-AI vs. Induction Healthcare Group Trellus Health Feedback DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix IQ-AI (LON:IQAI) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Is IQAI or INHC more profitable? Induction Healthcare Group has a net margin of -40.70% compared to IQ-AI's net margin of -77.52%. Induction Healthcare Group's return on equity of -26.97% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets IQ-AI-77.52% -140.75% -22.03% Induction Healthcare Group -40.70%-26.97%-7.32% Does the MarketBeat Community believe in IQAI or INHC? Induction Healthcare Group received 8 more outperform votes than IQ-AI when rated by MarketBeat users. Likewise, 93.33% of users gave Induction Healthcare Group an outperform vote while only 66.67% of users gave IQ-AI an outperform vote. CompanyUnderperformOutperformIQ-AIOutperform Votes666.67% Underperform Votes333.33% Induction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67% Do institutionals & insiders have more ownership in IQAI or INHC? 46.3% of Induction Healthcare Group shares are held by institutional investors. 66.0% of IQ-AI shares are held by insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings & valuation, IQAI or INHC? IQ-AI has higher earnings, but lower revenue than Induction Healthcare Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQ-AI£538.19K5.77N/AN/AN/AInduction Healthcare Group£12.57M0.51-£5.12M-£5.54-1.26 Does the media favor IQAI or INHC? In the previous week, IQ-AI and IQ-AI both had 1 articles in the media. IQ-AI's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQ-AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Induction Healthcare Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility and risk, IQAI or INHC? IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its stock price is 141% less volatile than the S&P 500. SummaryInduction Healthcare Group beats IQ-AI on 8 of the 11 factors compared between the two stocks. Get IQ-AI News Delivered to You Automatically Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQAI vs. The Competition Export to ExcelMetricIQ-AIHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£3.10M£209.05M£5.85B£2.63BDividend Yield17.30%6.68%4.76%4.98%P/E Ratio-13.67331.1516.51163.28Price / Sales5.77463.79450.02312,084.15Price / Cash10.2547.1438.0128.02Price / BookN/A5.267.645.14Net IncomeN/A-£15.55M£3.18B£5.73B7 Day Performance-6.04%-4.63%-1.95%-0.99%1 Month Performance-27.08%-1.87%-0.23%-0.81%1 Year Performance-8.02%13.07%16.69%39.26% IQ-AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQAIIQ-AIN/AGBX 1.40-3.4%N/A-36.4%£3.10M£538,190.00-13.676News CoverageGap UpINHCInduction Healthcare GroupN/AGBX 7.90-7.1%N/A-56.4%£7.41M£13.65M-263.3374Gap DownTRLSTrellus HealthN/AGBX 2.10flatN/A-55.0%£3.39M£35,000.00-70.0031Gap DownFDBKFeedbackN/AGBX 19-1.3%N/A-71.0%£2.53M£1.18M-76.0024DVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware2.5707 of 5 starsGBX 1,985+3.4%GBX 2,700+36.0%-8.8%£701.50M£189.27M7,634.62734Positive NewsINSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500KOOKooth2.7275 of 5 starsGBX 165.90+3.4%GBX 583.33+251.6%-42.3%£60.52M£54.17M1,382.50478RENXRenalytixN/AGBX 12+4.3%N/A-56.9%£19.91M£2.29M-50.00102Gap Down Related Companies and Tools Related Companies Induction Healthcare Group Alternatives Trellus Health Alternatives Feedback Alternatives DeepVerge Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Kooth Alternatives Renalytix Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IQAI) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ-AI Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IQ-AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
